LumiraDx: Transforming community-based healthcare

16 Oct 2022
LumiraDx: Transforming community-based healthcare

In this video, learn more about LumiraDx and its next-generation point-of-care diagnostic platform which combines a small, portable Instrument; microfluidic Test Strip; simple, standardized workflow; and seamless, secure digital connectivity to cloud and hospital IT systems.

About the company

LumiraDx logo

LumiraDx

LumiraDx was founded in 2014 by a group of entrepreneurs with a successful track record in building and scaling diagnostics and health IT businesses. As industry leading innovators, we have developed a next-generation point of care Platform, that is transforming community-based healthcare. Our technology provides fast, high performance and accessible diagnostic solutions at the point of need.

LumiraDx Platform

LumiraDx

Next-generation point of care diagnostic platform - Next-generation microfluidic technology on the LumiraDx Platform enables lab-comparable performance across a broad menu of diagnostic assays.

(0)

Other videos from LumiraDx

Links

Tags

Point-of-CarePoint-of-Care Testing (POCT) or Near Patient Testing (NPT) products are available for urine, blood and other clinical chemistry analyses. POCT includes: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing (PT / INR), rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.
LumiraDx: Transforming community-based healthcare